Aurinia Pharmaceuticals Inc. (AUPH) Stock

Aurinia Pharmaceuticals Inc. (AUPH) is a Healthcare stock trading at $16.49 (as of 2026-06-18), with a market capitalization of $2.02B and a trailing P/E of 7.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Aurinia Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company developing and commercializing therapies for diseases with unmet medical need in the United States and internationally. Its product portfolio includes LUPKYNIS for adult patients with active lupus nephritis, and it also has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd.

Valuation — source: SEC EDGAR (first-party)
Price$16.49
Market Cap$2.02B
P/E Ratio7.3
EV / EBITDA13.9
Price / Book3.58
Price / Sales6.82
DCF Value (model)$17.97
DCF Upside vs Price9.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$283.06M
Net Margin101.5%
Return on Equity52.5%
Current Ratio5.55
Revenue Growth (YoY)20.4%
EPS Growth (YoY)5250.0%
Financial Health — source: SEC EDGAR
Altman Z-Score7.99 (safe)
Valuation vs Sector & Industry
Stock P/E7.3
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-65.1%
vs Industry-57.6%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderTANG CAPITAL MANAGEMENT LLC ($181.24M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOPeter S. Greenleaf
Employees130
CountryCA
IPO Date2014-09-03

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Sarepta Therapeutics, Inc. (SRPT)
  • Ultragenyx Pharmaceutical Inc. (RARE)
  • Harmony Biosciences Holdings, Inc. (HRMY)
  • Recursion Pharmaceuticals, Inc. (RXRX)
  • Maze Therapeutics, Inc. (MAZE)
  • Olema Pharmaceuticals, Inc. (OLMA)
  • ImmunityBio, Inc. (IBRX)
  • Perrigo Company plc (PRGO)
AUPH earnings history · AUPH institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.